drugset / Trial / NCT04283877

The Role of Methylphenidate on Performance in the Cold

NCT04283877 ↗

Phase 4 Unknown 24 enrolled Brock University
RandomizedCrossoverSingle-blindBasic science

Summary

The purpose is to study the effects of dopamine activity, using methylphenidate ingestion, on exercise and cognitive function over the course of a progressive cooling protocol. The investigators hypothesize that methylphenidate will minimize the previously reported impairment in exercise performance and cognitive function with mild hypothermia and cold stress (air temperature: 0˚C) compared to placebo, suggesting that dopamine activity preserves exercise and cognitive capacity with mild hypothermia.

Timeline

Start
2019-12-15
Primary completion
2021-12-31
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylphenidate Small molecule 30 mg Oral

Indications

No indication recorded.